Loading
Life sciences · Journal article
Advanced Functional Materials · September 28, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT Triple‐negative breast cancer (TNBC) remains a significant clinical challenge due to lack of targetable biomarkers and systemic toxicity of conventional chemotherapy. To address these hurdles, we engineered a bioinspired “dragon‐fruit‐mimetic” nanoplatform (GemSe@PDA), with selenium quantum dots (SeQDs) and gemcitabine (Gem) uniformly dispersed in polydopamine (PDA) matrix that acts as a functional photothermal carrier. This distinctive structural endows high drug loading capacity, and the PDA matrix degrades under lysosomal acidic conditions (pH ∼5.0), enabling stimuli‐responsive release of SeQDs and Gem. GemSe@PDA shows uniform morphology (174.8 nm in diameter) and excellent photothermal capability of raising local temperature to 48.3°C within 10 min. Functionally, the GemSe@PDA nanoplatform integrates three modalities of SeQD‐driven apoptosis, PDA‐mediated photothermal ablation under 808 nm NIR irradiation, and Gem‐induced chemotherapy. Mechanistically, RNA‐seq analysis revealed that SeQDs provoke apoptosis by regulating the Akt/caspase‐3 signaling pathway, while Gem triggers cell cycle arrest. In vivo studies demonstrated that GemSe@PDA markedly boosts tumor‐targeted accumulation and effectively suppresses tumor growth, lowering the tumor weight to merely 15.9% of the control group without systemic toxicity. By combining the structural advantages of a dragon fruit‐like design with bioactive SeQDs, this nanoplatform provides a versatile, biocompatible strategy for overcoming the therapeutic problems of TNBC.